Fibrinogen - The key to familial CHD or just another shadow in Plato's allegory?

European Heart Journal

Volumn 23, Issue 16, 2002, Pages 1231-1233

  Sehnal, E ^a   Slany, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; BIOLOGICAL MARKER;

CIGARETTE SMOKING; DIABETES MELLITUS; DYSLIPIDEMIA; EDITORIAL; FAMILIAL DISEASE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE AGGREGATION; BLOOD; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION; GENETICS; NOTE; PROGNOSIS;

BIOLOGICAL MARKERS; CORONARY DISEASE; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 0036669196     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3248     Document Type: Editorial

References (12)

1. Folsom AR, Wu KK, Conlan MG. Fibrinogen and cardiovascular risk in the atherosclerosis risk in communities (ARIC) study. In: Ernst E et al., eds. Fibrinogen a New Cardiovascular Risk Factor 1992, pp. 124-9. Blackwell-MZV.
2. Barker et al. Relation of fetal and infant growth to plasma fibrinogen in adult live. Br Med J 1992; 304: 148-52.
3. Tsutsumi et al. Association between job characteristics and plasma fibrinogen in a normal working population. J Epidemiol Community Health 1999; 53: 348-54.
4. Lacoviello L et al. Genes encoding fibrinogen and cardiovascular risk. Hypertension 2001; 38: 1199-203.
5. Humphries SE et al. European Atherosclerosis Research Study; genotype at the fibrinogen locus (G-455-Abeta gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Arterioscler Thromb Vasc Biol 1992; 15: 96-104.
6. Folsom AR et al. Beta fibrinogen gene-455G/A polymorphism and coronary heart disease incidence: ARIC Study. Ann Epidemiol 2001; 11: 166-70.
7. Nishiuma S et al. Genetic variation in the promotor region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population. Blood Coagul Fibrinolysis 1998; 9: 373-9.
8. Gardemann A et al. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels but not to coronary artery disease and myocardial infarction. Thromb Haemost, 1997; 77: 1120-6.
9. Droggen CJ et al. Interaction of coagulation defects and cardiovascular risk factors. Circulation 1998; 97: 1037-41.
10. Kohler HP et al. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med; 342: 1792-801.
11. Bottinger C et al. HPA-1 and HPA-3 polymorphisms of platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 2000; 83: 559-62.
12. Laule M et al. A1/A2 polymorphism of glycoprotein 3a and association with excess procedural risk for coronary catheter interventions; a case controlled study. Lancet 1999; 353: 708-12.